Acura Pharmaceuticals Inc (ACUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 210 | 341 | 5,357 | 529 | 145 |
| Cost of Goods | 132 | 98 | 324 | 39 | 108 |
| Gross Profit | 78 | 243 | 5,033 | 490 | 37 |
| Operating Expenses | 2,615 | 2,739 | 3,845 | 2,984 | 2,791 |
| Operating Income | -2,405 | -2,398 | 1,512 | -2,455 | -2,646 |
| Interest Expense | 283 | 301 | 308 | 606 | 304 |
| Other Income | 39 | 36 | 35 | 365 | 46 |
| Pre-tax Income | -2,649 | -2,663 | 1,239 | -2,696 | -2,904 |
| Net Income Continuous | -2,649 | -2,663 | 1,239 | -2,696 | -2,904 |
| Net Income | $-2,649 | $-2,663 | $1,239 | $-2,696 | $-2,904 |
| EPS Basic Total Ops | -0.23 | -0.27 | 0.13 | -0.30 | -0.30 |
| EPS Basic Continuous Ops | -0.23 | -0.27 | 0.13 | -0.28 | -0.30 |
| EPS Diluted Total Ops | -0.23 | -0.27 | 0.13 | -0.30 | -0.30 |
| EPS Diluted Continuous Ops | -0.23 | -0.27 | 0.13 | -0.28 | -0.30 |
| EBITDA(a) | $-2,243 | $-2,234 | $1,683 | $-2,174 | $-2,504 |